Literature DB >> 14510795

Five-year risk of progression of primary angle closure to primary angle closure glaucoma: a population-based study.

Ravi Thomas1, Rajul Parikh, Jayaprakash Muliyil, Rajesh S Kumar.   

Abstract

OBJECTIVE: To report the 5-year progression to primary angle closure glaucoma (PACG) in a population-based cohort of primary angle closure (PAC) subjects.
METHODS: A total of 37 patients diagnosed as PAC during a population-based study in 1995 were invited for re-examination in 2000. Patients underwent a complete ophthalmic examination including ocular biometry. Progression to PACG was based on optic disc damage and field defects on automated perimetry.
RESULTS: In all, 28 of 32 PAC subjects who could be contacted presented for examination. Eight (28.5%; 95% CI 12-45%) had progressed to PACG; two of seven with appositional and six of 21 with synechial closure. All were advised laser peripheral iridotomy (LPI) in 1995; one of the nine who underwent LPI progressed compared to seven of 19 who refused LPI. Four of those originally diagnosed with appositional closure developed peripheral anterior synechiae. One eye of a person previously diagnosed with appositional PAC was reclassified as a primary angle closure suspect (PACS). There was no significant difference in biometric parameters between those who progressed and those who did not. None developed acute PACG or blindness due to glaucoma.
CONCLUSION: In this population-based study of primary angle closure, the 5-year incidence of PACG was eight patients (28.5%; 95% CI 12-45%). We were unable to identify any features that predicted progression.

Entities:  

Mesh:

Year:  2003        PMID: 14510795     DOI: 10.1034/j.1600-0420.2003.00135.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  42 in total

Review 1.  The future of glaucoma clinics.

Authors:  A M S Morley; I Murdoch
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  Prevention of primary angle-closure glaucoma in Asia.

Authors:  Winifred P Nolan
Journal:  Br J Ophthalmol       Date:  2007-07       Impact factor: 4.638

3.  How to manage a patient with glaucoma in Asia.

Authors:  Jennifer Ly Yip; Paul J Foster
Journal:  Community Eye Health       Date:  2006-09

4.  Five-year incidence of angle closure among glaucoma health examination participants.

Authors:  Kenji Kashiwagi; Tatsuya Chiba; Fumihiko Mabuchi; Toshie Furuya; Shigeo Tsukahara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-25       Impact factor: 3.117

5.  Outflow facility and extent of angle closure in a porcine model.

Authors:  Ying Hong; Chao Wang; Ralitsa Loewen; Susannah Waxman; Priyal Shah; Si Chen; Hamed Esfandiari; Nils A Loewen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-04-03       Impact factor: 3.117

6.  Deep Learning Classifiers for Automated Detection of Gonioscopic Angle Closure Based on Anterior Segment OCT Images.

Authors:  Benjamin Y Xu; Michael Chiang; Shreyasi Chaudhary; Shraddha Kulkarni; Anmol A Pardeshi; Rohit Varma
Journal:  Am J Ophthalmol       Date:  2019-08-22       Impact factor: 5.258

7.  Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma.

Authors:  Zhichao Wu; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  Am J Ophthalmol       Date:  2018-08-10       Impact factor: 5.258

Review 8.  Gonioscopy findings and prevalence of occludable angles in a Burmese population: the Meiktila Eye Study.

Authors:  R J Casson; H S Newland; J Muecke; S McGovern; L M Abraham; W K Shein; D Selva; T Aung
Journal:  Br J Ophthalmol       Date:  2007-07       Impact factor: 4.638

Review 9.  Importance of population-based studies in clinical practice.

Authors:  George Ronnie; Ramesh Sathyamangalam Ve; Lokapavani Velumuri; Rashima Asokan; Lingam Vijaya
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

10.  Intermediate results of phaco-endocycloplasty in an exclusive cohort of angle closure glaucoma: potential for change.

Authors:  Vanita Pathak-Ray
Journal:  Int Ophthalmol       Date:  2019-01-03       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.